Patents by Inventor Fernando Pedro Cossío Mora

Fernando Pedro Cossío Mora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390308
    Abstract: Compounds derived from ursodeoxycholic acid of formula (I) and to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Application
    Filed: July 17, 2023
    Publication date: December 7, 2023
    Inventors: Jesus Maria BANALES ASURMENDI, Luis BUJANDA FERNANDEZ DE PIEROLA, Alvaro SANTOS LASO, Fernando Pedro COSSIO MORA, Ivan RIVILLA DE LA CRUZ, Francisco Javier CABALLERO CAMINO, Manel ESTELLER BADOSA, Jose Juan GARCIA MARIN
  • Patent number: 11833160
    Abstract: The present invention relates to compounds derived from ursodeoxycholic acid of formula (I), to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: December 5, 2023
    Assignees: UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA, ADMINISTRACIO GENERAL DE LA COMUNIDAD AUTONOMA DE EUSKADI, FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL), UNIVERSIDAD DE SALAMANCA
    Inventors: Jesus Maria Banales Asurmendi, Luis Bujanda Fernandez De Pierola, Alvaro Santos Laso, Fernando Pedro Cossio Mora, Ivan Rivilla De La Cruz, Francisco Javier Caballero Camino, Manel Esteller Badosa, Jose Juan Garcia Marin
  • Publication number: 20210137946
    Abstract: The present invention relates to compounds derived from ursodeoxycholic acid of formula (I), to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Application
    Filed: December 28, 2018
    Publication date: May 13, 2021
    Inventors: Jesus Maria BANALES ASURMENDI, Luis BUJANDA FERNANDEZ DE PIEROLA, Alvaro SANTOS LASO, Fernando Pedro COSSIO MORA, Ivan RIVILLA DE LA CRUZ, Francisco Javier CABALLERO CAMINO, Manel ESTELLER BADOSA, Jose Juan GARCIA MARIN
  • Publication number: 20160122340
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, neurological disorders and immunological disorders.
    Type: Application
    Filed: May 9, 2014
    Publication date: May 5, 2016
    Inventors: Fernando Pedro COSSÍO MORA, Yosu Ion VARA SALAZAR, María del Carmen MASDEU MARGALEF, María Remedios ALCALÁ CAFFARENA, Sergio VILLAFRUELA CÁNEVA, Dorleta OTAEGUI ANSA, Eneko ALDABA ARÉVALO, Aizpea ZUBIA OLASCOAGA, Eider SAN SEBASTIÁN LARZABAL
  • Publication number: 20150336889
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, genetic diseases, neurological disorders and immunological disorders.
    Type: Application
    Filed: November 7, 2013
    Publication date: November 26, 2015
    Inventors: Fernando Pedro COSSÍO MORA, Yosu Ion VARA SALAZAR, María del Carmen MASDEU MARGALEF, María Remedios ALCALÁ CAFFARENA, Sergio VILLAFRUELA CÁNEVA, Dorleta OTAEGUI ANSA, Eneko ALDABA ARÉVALO, Eider SAN SEBASTIÁN LARZABAL, Aizpea ZUBIA OLASCOAGA
  • Publication number: 20150038545
    Abstract: The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.
    Type: Application
    Filed: April 4, 2012
    Publication date: February 5, 2015
    Applicants: UNIVERSIDAD DEL PAÍS VASCO, IKERCHEM, S.L.
    Inventors: Fernando Pedro Cossío Mora, Yosu Ion Vara Salazar, Eider San Sebastián Larzabal, Dorleta Otaegui Ansa, María del Carmen Masdeu Margalef, Eneko Aldaba Arévalo, Maialen Aginagalde Unanue, Sergio Villafruela Cáneva, María Remedios Alcalá Caffarena, Aizpea ZUubia Olascoaga
  • Patent number: 8835659
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer, aging related diseases or processes, diabetes and neurodegenerative diseases.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: September 16, 2014
    Assignees: Ikerchem, S.L., Universidad del Pais Vasco
    Inventors: Fernando Pedro Cossio Mora, Leire Lidia Arias Echeverría, Yosu Ion Vara Zalazar, Eneko Aldaba Arévalo, Eider San Sebastián Larzabal, Aizpea Zubia Olascoaga
  • Patent number: 8685992
    Abstract: The present invention refers to compounds derived from trisubstituted 1H-pyrrole rings and aromatic rings, which have the following formula (I): wherein: R1 and R2 represent, independently, an optionally substituted C6-C10 aryl radical or an optionally substituted heteroaryl radical; A and M represent, independently, a methylene group or a single bond, in which case the adjacent aromatic ring would be attached directly to the amide group; the Y?Z group represents together and indistinctly an oxygen atom, a sulfur atom, a cis-vinylidene group, an imino group, or a methine group with a sp2-hybridized carbon atom; X represents indistinctly a methine group, a cis-vinylidene group or a nitrogen atom; and W represents a hydroxyl group, an optionally substituted C1-C6 alkyl group, an optionally substituted heteroaryl group or an optionally substituted C6-C10 aryl group; or a salt, solvate or prodrug thereof, as well as to the process for their preparation and the use thereof for the treatment of cancer.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: April 1, 2014
    Assignees: Universidad del País Vasco, Ikerschem, S.L.
    Inventors: Fernando Pedro Cossío Mora, Aizpea Zubia Olascoaga, Yosu Vara Salazar, Eider Ion San Sebastián Larzabal, Dorleta Otaegui Ansa, María del Carmen Masdeu Margalef, Eneko Aldaba Arévalo
  • Publication number: 20130217730
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer, aging related diseases or processes, diabetes and neurodegenerative diseases.
    Type: Application
    Filed: May 10, 2011
    Publication date: August 22, 2013
    Applicant: IKERCHEM, S.L.
    Inventors: Fernando Pedro Cossio Mora, Leire Lidia Arias Echeverría, Yosu Ion Vara Zalazar, Eneko Aldaba Arévalo, Eider San Sebastián Larzabal, Aizpea Zubia Olascoaga
  • Publication number: 20120196885
    Abstract: The present invention refers to compounds derived from trisubstituted 1H-pyrrole rings and aromatic rings, which have the following formula (I): wherein: R1 and R2 represent, independently, an optionally substituted C6-C10 aryl radical or an optionally substituted heteroaryl radical; A and M represent, independently, a methylene group or a single bond, in which case the adjacent aromatic ring would be attached directly to the amide group; the Y?Z group represents together and indistinctly an oxygen atom, a sulfur atom, a cis-vinylidene group, an imino group, or a methine group with a sp2-hybridized carbon atom; X represents indistinctly a methine group, a cis-vinylidene group or a nitrogen atom; and W represents a hydroxyl group, an optionally substituted C1-C6 alkyl group, an optionally substituted heteroaryl group or an optionally substituted C6-C10 aryl group; or a salt, solvate or prodrug thereof, as well as to the process for their preparation and the use thereof for the treatment of cancer.
    Type: Application
    Filed: October 1, 2010
    Publication date: August 2, 2012
    Applicant: IKERCHEM, S.L.
    Inventors: Fernando Pedro Cossío Mora, Aizpea Zubia Olascoaga, Yosu Vara Salazar, Eider Ion San Sebastián Larzabal, Dorleta Otaegui Ansa, María del Carmen Masdeu Margalef, Eneko Aldaba Arévalo
  • Patent number: 7943660
    Abstract: The invention relates to the treatment of disorders or diseases mediated by LFA-1/ICAM-1 molecular interaction. This is based on the use of novel chemical compounds capable of inhibiting said interaction, and more particularly, to pharmaceutical compositions containing these compounds.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: May 17, 2011
    Assignee: Dominion Pharmakine S.L.
    Inventors: Natalia Gallot Escobal, Fernando Vidal Vanaclocha, Fernando Pedro Cossio Mora, Miren Lorea Mendoza Arteche, Aizpea Zubia Olascoaga, Maria Valcarcel Cuesta, Yosu Ion Vara Salazar, Miren Sorne Solaun Aguirre, Jose Javier Lopez Pestana, Eider San Sebastian Larzabal
  • Patent number: 7638550
    Abstract: The invention describes new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases.
    Type: Grant
    Filed: December 27, 2005
    Date of Patent: December 29, 2009
    Assignee: Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU) Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO)
    Inventors: Fernando Pedro Cossio Mora, Manel Esteller Badosa, Aizpea Zubia Olascoaga, Dorleta Otaegui Ansa
  • Publication number: 20080262073
    Abstract: The invention describes new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases.
    Type: Application
    Filed: December 27, 2005
    Publication date: October 23, 2008
    Inventors: Fernando Pedro Cossio Mora, Manel Esteller Badosa, Aizpea Zubia Olascoaga, Dorleta Otaegui Ansa
  • Publication number: 20080249157
    Abstract: The invention relates to the treatment of disorders or diseases mediated by LFA-1/ICAM-1 molecular interaction. This is based on the use of novel chemical compounds capable of inhibiting said interaction, and more particularly, to pharmaceutical compositions containing these compounds.
    Type: Application
    Filed: November 14, 2005
    Publication date: October 9, 2008
    Applicants: DOMINION PHARMAKINE S.L., UNIVERSIDAD DEL PAIS VASCO
    Inventors: Fernando Pedro Cossio Mora, Eider San Sebastian Larzabal, Miren Lorea Mendoza Arteche, Aizpea Zubia Olascoaga, Maria Valcarcel Cuesta, Yosu Ion Vara Salazar, Miren Sorne Solaun Aguirre, Jose Javier Lopez Pestana, Natalia Gallot Escobal, Fernando Vidal Vanaclocha